3-[1-(Dimethylamino)ethyl]phenyl Ethyl(methyl)carbamate - CAS 105601-20-5
Catalog: |
BB001674 |
Product Name: |
3-[1-(Dimethylamino)ethyl]phenyl Ethyl(methyl)carbamate |
CAS: |
105601-20-5 |
Synonyms: |
N-ethyl-N-methylcarbamic acid [3-[1-(dimethylamino)ethyl]phenyl] ester; [3-[1-(dimethylamino)ethyl]phenyl] N-ethyl-N-methylcarbamate |
IUPAC Name: | [3-[1-(dimethylamino)ethyl]phenyl] N-ethyl-N-methylcarbamate |
Description: | 3-[1-(Dimethylamino)ethyl]phenyl Ethyl(methyl)carbamate (CAS# 105601-20-5) is a brain selective acetylcholinesterase inhibitor. Nootropic. |
Molecular Weight: | 250.34 |
Molecular Formula: | C14H22N2O2 |
Canonical SMILES: | CCN(C)C(=O)OC1=CC=CC(=C1)C(C)N(C)C |
InChI: | InChI=1S/C14H22N2O2/c1-6-16(5)14(17)18-13-9-7-8-12(10-13)11(2)15(3)4/h7-11H,6H2,1-5H3 |
InChI Key: | XSVMFMHYUFZWBK-UHFFFAOYSA-N |
LogP: | 2.75970 |
Publication Number | Title | Priority Date |
US-10639315-B1 | Pharmaceutical compositions and methods for treating Alzheimer's disease | 20190521 |
US-2020323871-A1 | Novel pharmaceutical compositions and methods for treating parkinson's and huntington's disease | 20190412 |
US-2020258610-A1 | Systems for Monitoring Compliance with a Patch Dosage Regimen and Methods of Using the Same | 20190207 |
US-10998091-B2 | Systems for monitoring compliance with a patch dosage regimen and methods of using the same | 20190207 |
US-2020155476-A1 | Transdermal patch | 20181116 |
PMID | Publication Date | Title | Journal |
32092302 | 20200301 | An in vitro study on the interaction of the anti-Alzheimer drug rivastigmine with human erythrocytes | Chemico-biological interactions |
29739252 | 20181201 | Evaluation of the rivastigmine role against botulinum toxin-A-induced osteoporosis in albino rats: A biochemical, histological, and immunohistochemical study | Human & experimental toxicology |
29777723 | 20180801 | Effect of acetylcholinesterase inhibitors donepezil and rivastigmine on the activity and expression of cyclooxygenases in a model of the inflammatory action of fluoride on macrophages obtained from THP-1 monocytes | Toxicology |
23728651 | 20130531 | Rivastigmine for vascular cognitive impairment | The Cochrane database of systematic reviews |
23123248 | 20130325 | Inhibition of human carboxylesterases hCE1 and hiCE by cholinesterase inhibitors | Chemico-biological interactions |
Complexity: | 269 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 250.168127949 |
Formal Charge: | 0 |
Heavy Atom Count: | 18 |
Hydrogen Bond Acceptor Count: | 3 |
Hydrogen Bond Donor Count: | 0 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 250.168127949 |
Rotatable Bond Count: | 5 |
Topological Polar Surface Area: | 32.8 |
Undefined Atom Stereocenter Count: | 1 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 2.3 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Carbonyl Compounds
Customers Also Viewed
-
[1408282-26-7]
8-Fluoro-4,5-dihydro-1H-azepino[5,4,3-CD]indol-6(3H)-one
-
[1115-70-4]
1,1-Dimethylbiguanide hydrochloride
-
[91054-33-0]
2-acetylbenzenecarbonitrile
-
[947533-45-1]
2-Bromo-5-fluoropyrimidine
-
[76931-93-6]
N-Succinimidyl-S-acetylthioacetate
-
[1388152-02-0]
1,2-Cyclopentanediol, 3-amino-5-[(phosphonooxy)methy]-, ammonium salt (1:2), (1R,2S,3R,5R)-
INDUSTRY LEADERS TRUST OUR PRODUCTS